Skip to content
Stop using now Drug recall · FDA · Published April 18, 2014

Hospira Recalls Lidocaine HCl Vials Due to Particulate Matter

Hospira recalls 1% Lidocaine HCl injection vials due to iron oxide particulates. Check lot 31-427-DK and expiration date July 1, 2015.

🇺🇸 FDA recall #D-0382-2015DrugHospira ›
Take action

Contact the company

Recalling firmHospira Inc.375 N Field Dr · Lake Forest, IL 60045-2513
✎ GovInfoNow plain-language explainer

Hospira Inc. is recalling 1% LIDOCAINE HCl Injection, USP, Preservative-Free, 10 mg/mL, 30 mL single-dose vials because they contain confirmed particulate matter. Specifically, orange and black particles identified as iron oxide were found embedded in the glass and floating in the solution. This recall affects a total of 120,900 vials distributed nationwide. Read more at govinfonow.com/recall/46125-hospira-inc-recalls-1-lidocaine-hcl-injection-usp-preservative-free.

Source Summary by GovInfoNow · govinfonow.com/recall/46125-hospira-inc-recalls-1-lidocaine-hcl-injection-usp-preservative-free · Updated October 13, 2026 · FDA enforcement record: FDA #D-0382-2015

Cite this page

“Hospira Recalls Lidocaine HCl Vials Due to Particulate Matter.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46125-hospira-inc-recalls-1-lidocaine-hcl-injection-usp-preservative-free. Based on FDA recall #D-0382-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0382-2015%22&limit=1).

The FDA announced on April 18, 2014, that Hospira Inc. is recalling 1% LIDOCAINE HCl Injection vials due to the presence of iron oxide particulates. The agency classified this Class I recall as voluntary.

How to tell if you have it

  • Brand: Hospira
  • Product: 1% LIDOCAINE HCl Injection, USP, Preservative-Free, 10 mg/mL, 30 mL Single-dose vials
  • Packaging: 25-count cartons
  • NDC: 0409-4279-02
  • Lot number: 31-427-DK
  • Expiration date: 01JUL2015
  • Units affected: 120,900 vials

The hazard

The recall addresses confirmed customer complaints of orange and black particulates, identified as iron oxide, found embedded within the glass vial and floating in the solution. The FDA classified this defect as a Class I hazard.

Context

GovInfoNow's records show Hospira Inc. has had 108 other recalls on record since April 5, 2012. Other recent recalls of similar products include American Regent Papaverine HCl Injection (July 24, 2026), Asclemed Lidocaine HCl Injection (June 8, 2026), and Huons Lidocaine HCl Injection (April 2, 2026).

How to tell if you have this one

Look for single-dose vials of 1% LIDOCAINE HCl Injection, USP, Preservative-Free, 10 mg/mL, 30 mL. The product is packaged in 25-count cartons with NDC 0409-4279-02. The affected lot number is 31-427-DK and the expiration date is 01JUL2015.

  • Brand
    Hospira
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Stop using the product

    Do not use any vials matching the recalled lot number due to the presence of iron oxide particulates.

  2. Check your inventory

    Verify if you have vials with NDC 0409-4279-02, lot number 31-427-DK, expiring on July 1, 2015.

  3. Contact your supplier

    Reach out to the distributor or manufacturer for further instructions on returning or disposing of the recalled vials.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 3.6 years after the firm started it.

1. Firm started the recall: Apr 18, 201412. FDA classified it Class I: Jan 30, 201523. Published in FDA’s Enforcement Report: Feb 11, 201534. FDA terminated the recall: Nov 7, 2017420142017
  1. Firm started the recall
  2. FDA classified it Class I
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0382-2015 (April 18, 2014) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0382-2015 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA